Additionally, exploring alternative treatment approaches, such as SSTR2 upregulation (28, 43) and the use of radiosensitizers (44, 45), may be beneficial to improve the outcomes for HR-NB patients with a mixed response to 177Lu-DOTATATE. Here, SSTR2 is linked to neuroblastoma.